Clinical and laboratory parameters associated with death in acute pancreatitis
Abstract
Background/Aim. Acute pancreatitis is an inflammatory condition having the significant mortality rate in the case of severe forms of the disease. The aim of this study was to investigate putative factors of increased mortality in patients with acute pancreatitis with contradictory prior evidence, and to reveal factors that were insufficiently explored previously. Methods. This prospective cohort study with nested case/control design included all adult patients treated for acute pancreatitis in the Clinical Center of Kragujevac, Serbia, during the 3-year period (from October 2011 to December 2014). The cases (n = 19) were patients who died, while the controls (n = 113) were patients who survived. The associations between putative risk factors and the study outcomes were tested by univariate and multivariate logistic regressions, and expressed as crude and adjusted odds ratios (OR) with corresponding 95% confidence intervals (CI). Results. Significant association with the lethal outcome in acute pancreatitis was found for advanced age (adjusted OR 1.12, 95%CI 1.02–1.23), presence of significant comorbidities (adjusted OR 10.62, 95%CI 1.01–111.39), higher interleukin-8 (IL-8) value on third day from onset of symptoms (adjusted OR 1.05, 95%CI 1.02–1.08), use of tramadol and/or morphine (adjusted OR 47.34, 95%CI 3.21–699.08), the Bedside index for severity in acute pancreatitis (BISAP) score ≥ 3 in the first 24 hours (adjusted OR 48.11, 95%CI 3.14–736.29), and prophylactic use of antibiotics (adjusted OR 0.07, 95%CI 0.01–0.85). Conclusion. Advanced age, significant comorbidities, use of tramadol and/or morphine and more severe disease as assessed by BISAP score can increase the risk of death in acute pancreatitis, while prophylactic use of antibiotics may have a protective role.
References
Brunicardi F, Andersen D, Billiar T, Dunn D, Hunter J, Matthews J, et al. Schwartz's principles of surgery. 10th ed. New York: McGraw-Hill Education; 2014.
Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc 2002; 56(6 Suppl): S226−30.
Roberts SE, Akbari A, Thorne K, Atkinson M, Evans PA. The in-cidence of acute pancreatitis: Impact of social deprivation, al-cohol consumption, seasonal and demographic factors. Ali-ment Pharmacol Ther 2013; 38(5): 539−48.
Rohan JD, Osman HG, Patel S. Severe acute pancreatitis attacks are associated with significant morbidity and mortality. Curr Probl Surg 2014; 51(9): 370−2.
Staubli SM, Oertli D, Nebiker CA. Laboratory markers predicting severity of acute pancreatitis. Crit Rev Clin Lab Sci 2015; 52(6): 273−83.
Zhou J, Li Y, Tang Y, Liu F, Yu S, Zhang L, et al. Effect of acute kidney injury on mortality and hospital stay in patient with severe acute pancreatitis. Nephrology (Carlton) 2015; 20(7): 485−91.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13(10): 818‒29.
Zhu AJ, Shi JS, Sun XJ. Risk factors influencing mortality of patients with severe acute pancreatitis within 24 hours after admission. Hepatobiliary Pancreat Dis Int 2003; 2(3): 453−7.
Wu BU, Johannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: A large population-based study. Gut 2008; 57(12): 1698−703.
Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139(1): 69‒81.
Gao W, Yang HX, Ma CE. The Value of BISAP Score for Pre-dicting Mortality and Severity in Acute Pancreatitis: A System-atic Review and Meta-Analysis. PLoS One 2015; 10(6): e0130412.
Busquets J, Fabregat J, Pelaez N, Millan M, Secanella L, Garcia-Borobia F, et al. Factors influencing mortality in patients undergoing surgery for acute pancreatitis: Importance of peri-pancreatic tissue and fluid infection. Pancreas 2013; 42(2): 285−92.
Lee BJ, Kim CD, Jung SW, Kwon YD, Kim YS, Yim HJ, et al. Analysis of the factors that affect the mortality rate in severe acute pancreatitis. Korean J Gastroenterol 2008; 51(1): 25−33.
De Waele JJ. Acute pancreatitis. Curr Opin Crit Care 2014; 20(2): 189−95.
Zou L, Ke L, Li W, Tong Z, Wu C, Chen Y, et al. Enteral nutri-tion within 72 h after onset of acute pancreatitis vs delayed ini-tiation.Eur J Clin Nutr 2014; 68(12): 1288−93.
Bassi C, Larvin M, Villatoro E. Antibiotic therapy for prophy-laxis against infection of pancreatic necrosis in acute pancreati-tis. Cochrane Database Syst Rev 2003; (4): CD002941.
Zhou YM, Xue ZL, Li YM, Zhu YQ, Cao N. Antibiotic prophy-laxia in patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2005; 4(1): 23−7.
Ukai T, Shikata S, Inoue M, Noguchi Y, Igarashi H, Isaji S, et al. Early prophylactic antibiotics administration for acute ne-crotizing pancreatitis: A meta-analysis of randomized con-trolled trials. J Hepatobiliary Pancreat Sci 2015; 22(4): 316−21.
Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001; 164(1): 162−70.
Digalakis MK, Katsoulis IE, Biliri K, Themeli-Digalakis K. Serum profiles of C-reactive protein, interleukin-8, and tumor necro-sis factor-α in patients with acute pancreatitis. HPB Surg 2009; 2009: 878490.
Mentula P, Kylänpää ML, Kemppainen E, Jansson SE, Sarna S, Puo-lakkainen P, et al. Early prediction of organ failure by com-bined markers in patients with acute pancreatitis. Br J Surg 2005; 92(1): 68−75.
Gravante G, Garcea G, Ong SL, Metcalfe MS, Berry DP, Lloyd DM, et al. Prediction of mortality in acute pancreatitis: A systematic review of the published evidence. Pancreatology 2009; 9(5): 601−14.
Fan JY, Huang ZW, Guo J. Value of four scoring systems for predicting prognosis of severe acute pancreatitis. Zhong Xi Yi Jie He Xue Bao 2009; 7(1): 34−40. (Chinese)
Losurdo G, Iannone A, Principi M, Barone M, Ranaldo N, Ierardi E, et al. Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission. Eur J Intern Med 2016; 30: 88−93.
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruin-ing H, et al. The SOFA (Sepsis-related Organ Failure Assess-ment) score to describe organ dysfunction/failure. On behalf of the WorkingGroup on Sepsis-Related Problems of the Eu-ropean Society of Intensive Care Medicine. Intensive Care Med 1996; 22(7): 707‒10.
Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pan-creatitis: Value of CT in establishing prognosis. Radiology 1990;174(2): 331−6.
Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128(5): 586−90.
Murata A, Ohtani M, Muramatsu K, Matsuda S. Influence of comorbidity on outcomes of older patients with acute pancreatitis based on a national administrative database. Hepatobiliary Pancreat Dis Int 2015; 14(4): 422−8.
Kong L, Santiago N, Han TQ, Zhang SD. Clinical characteristics and prognostic factors of severe acute pancreatitis. World J Gastroenterol 2004; 10(22): 3336−8.
Petrone MC, Arcidiacono PG, Perri F, Carrara S, Boemo C, Testoni PA. Chronic pancreatitis-like changes detected by endoscopic ultrasound in subjects without signs of pancreatic disease: do these indicate age-related changes, effects of xenobiotics, or early chronic pancreatitis?. Pancreatology 2010; 10(5): 597−602.
Ranson JH, Pasternack BS. Statistical methods for quantifying the severity of clinical acute pancreatitis. J Surg Res 1977; 22(2): 79−91.
Yeung YP, Lam B, Yip A. APACHE system is better than Ran-son system in the prediction of severity of acute pancreatitis. Hepatobiliary Pancreat Dis Int 2006; 5(2): 294−9.
Yang YX, Li L. Evaluating the Ability of the Bedside Index for Severity of Acute Pancreatitis Score to Predict Severe Acute Pancreatitis: A Meta-Analysis. Med Princ Pract 2016; 25(2): 137−42.
Zheng J, Zhang J, Gao J. Early evaluations of BISAP plus C-reactive protein in predicting the severity of acute pancreatitis. Zhonghua Yi Xue Za Zhi 2015; 95(12): 925−8. (Chinese)
Shabbir S, Jamal S, Khaliq T, Khan ZM. Comparison of BISAP Score with Ranson's Score in Determining the Severity of Acute Pancreatitis. J Coll Physicians Surg Pak 2015; 25(5): 328−31.
Yadav J, Yadav SK, Kumar S, Baxla RG, Sinha DK, Bodra P, et al. Predicting morbidity and mortality in acute pancreatitis in an Indian population: A comparative study of the BISAP score, Ranson's score and CT severity index. Gastroenterol Rep (Oxf) 2015. pii: gov009.
Park JY, Jeon TJ, Ha TH, Hwang JT, Sinn DH, Oh TH, et al. Bedside index for severity in acute pancreatitis: Comparison with other scoring systems in predicting severity and organ failure. Hepatobiliary Pancreat Dis Int 2013; 12(6): 645−50.
Ignatavicius P, Vitkauskiene A, Pundzius J, Dambrauskas Z, Barauskas G. Effects of prophylactic antibiotics in acute pan-creatitis. HPB (Oxford) 2012; 14(6): 396−402.
Arlt A, Erhart W, Schafmayer C, Held HC, Hampe J. Antibiosis of Necrotizing Pancreatitis. Viszeralmedizin 2014; 30(5): 318−24.
Nicholson LJ. Acute pancreatitis: Should we use antibiotics?. Curr Gastroenterol Rep 2011; 13(4): 336−43.
Rada G, Peña J. Is antibiotic prophylaxis beneficial in acute pancreatitis. Medwave 2015; 15(3): e6125.
Yao L, Huang X, Li Y, Shi R, Zhang G. Prophylactic antibiotics reduce pancreatic necrosis in acute necrotizing pancreatitis: A meta-analysis of randomized trials. Dig Surg 2010; 27(6): 442−9.
Jiang K, Huang W, Yang XN, Xia Q. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J Gastroenterol 2012; 18(3): 279−84.
Pezzilli R, Billi P, Miniero R, Barakat B. Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci 1997; 42(7): 1469−72.
Surbatovic M, Popovic N, Vojvodic D, Milosevic I, Acimovic G, Stojicic M, et al. Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci Rep 2015; 5: 11355.
Di Battista AP, Rhind SG, Hutchison MG, Hassan S, Shiu MY, Inaba K, et al. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J Neuroinflammation 2016; 13(1): 40.
Saxena A, Khosraviani S, Noel S, Mohan D, Donner T, Hamad AR. Interleukin 10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine 2015; 74(1): 27−34.
Chen D, Wang W, Wang J. Epidermal growth factor prevents increased permeability and bacterial translocation in rats with acute pancreatitis. Chin Med Sci J 2001; 16(1): 46−8.
Liu Q, Djuricin G, Nathan C, Gattuso P, Weinstein RA, Prinz RA. The effect of epidermal growth factor on the septic complica-tions of acute pancreatitis. J Surg Res 1997; 69(1): 171−7.
Sah RP, Garg P, Saluja AK. Pathogenic mechanisms of acute pancreatitis. Curr Opin Gastroenterol 2012; 28(5): 507−15.
Akshintala VS, Hutfless SM, Yadav D, Khashab MA, Lennon AM, Makary MA, et al. A population-based study of severity in pa-tients with acute on chronic pancreatitis. Pancreas 2013; 42(8): 1245−50.
Singh VK, Bollen TL, Wu BU, Repas K, Maurer R, Yu S, et al. An assessment of the severity of interstitial pancreatitis. Clin Gas-troenterol Hepatol 2011; 9(12): 1098−103.
Uomo G, Talamini G, Rabitti PG, Cataldi F, Cavallera A, Rengo F. Influence of advanced age and related comorbidity on the course and outcome of acute pancreatitis. Ital J Gastroenterol Hepatol 1998; 30(6): 616−21.
Ona BX, Comas RD, Urrútia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev 2013; (7): CD009179.
Pezzilli R, Uomo G, Gabbrielli A, Zerbi A, Frulloni L, de Rai P, et al. ProInf-AISP Study Group. A prospective multicentre sur-vey on the treatment of acute pancreatitis in Italy. Dig Liver Dis 2007; 39(9): 838−46.